Mouse IFN-γ(Interferon Gamma) ELISA Kit
中文名称:小鼠γ干扰素(IFN-γ)酶联免疫吸附测定试剂盒

Price:
- 反应性: Mouse
- 检测范围: 15.63-1000 pg/mL
- 灵敏度: 9.38 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠IFN-γ抗体包被于酶标板上,实验时样品(或标准品)中的小鼠IFN-γ会与包被抗体结合。后依次加入生物素化的抗小鼠IFN-γ抗体和辣根过氧化物酶标记的亲和素,抗小鼠IFN-γ抗体与结合在包被抗体上的小鼠IFN-γ结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,IFN-γ浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中IFN-γ的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Mouse |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 15.63-1000 pg/mL |
灵敏度 | 9.38 pg/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的小鼠IFN-γ,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
Single-cell data-driven design of armed oncolytic virus and combination therapy to activate a cooperative innate-adaptive immunity against cancer
IF: 12.100Journal: MOLECULAR THERAPY (2024)Reactivity:MouseSample Type:Pan02 cell-Xenograft -
Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy
IF: 10.000Journal: Advanced Healthcare Materials (2024)Reactivity:MouseSample Type:serum -
Tumor Microenvironment-Responsive Macrophage-Mediated Immunotherapeutic Drug Delivery
IF: 9.400Journal: Acta Biomaterialia (2024)Reactivity:MouseSample Type:serum -
Targeting the Autoreactive CD8 T-cell Receptor in Type 1 Diabetes: Insights from scRNA-seq for Immunotherapy
IF: 9.100Journal: PHARMACOLOGICAL RESEARCH (2024)Reactivity:MouseSample Type:serum -
Empagliflozin protects against heart failure with preserved ejection fraction partly by inhibiting the senescence-associated STAT1–STING axis
IF: 8.500Journal: Cardiovascular Diabetology (2024)Reactivity:MouseSample Type:Plasma -
OPA1 Mediated Fatty Acid β-Oxidation in Hepatocyte: The Novel Insight for Melatonin Attenuated Apoptosis in Concanavalin A Induced Acute Liver Injury
IF: 8.300 -
Metabolic regulating enhanced immunological activating nanocomposites for tumor microenvironment normalization and immunotherapy
IF: 8.200Journal: Materials Today Nano (2024)Reactivity:MouseSample Type:serum -
Epigenetic modification of CD4+ T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment
IF: 8.100Journal: Cell Death & Disease (2024)Reactivity:MouseSample Type:plasma -
Structural characterization and immunomodulatory activity of polysaccharides from the lateral roots of Aconitum carmichaelii
IF: 7.700Journal: INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2024)Reactivity:MouseSample Type:serum -
Combination application of Pickering emulsion and BLS protein nanoparticles enhances vaccine efficacy
IF: 7.700Journal: INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2024)Reactivity:Mouse